TXR1 Inhibitors
Chemical inhibitors of TXR1 function by interfering with various signaling pathways and enzymes that are crucial for the protein's activity within cellular processes. Wortmannin and LY294002, as inhibitors of phosphoinositide 3-kinases (PI3Ks), can lead to reduced activity of PI3K-dependent pathways, which are essential for the function of proteins like TXR1. The inhibition of these pathways by Wortmannin and LY294002 can result in the decreased functionality of TXR1. Additionally, Rapamycin, targeting the mTOR pathway, and PP242, which inhibits both mTORC1 and mTORC2 complexes, can suppress the mTOR signaling that may regulate TXR1 activity. This comprehensive inhibition of the mTOR pathway can lead to a reduction in the activity of proteins that are modulated by mTOR, including TXR1.
Furthermore, Spautin-1 can lead to the destabilization of TXR1 by inhibiting ubiquitin-specific peptidases like USP10 and USP13, which are involved in the stabilization of proteins. PD98059 and U0126, both MEK inhibitors, can attenuate the ERK pathway's activity, leading to reduced functionality of proteins regulated by this pathway, such as TXR1. Similarly, SB203580 targets p38 MAP kinase, thereby potentially reducing TXR1 activity by affecting the stress response and apoptotic pathways. Additionally, a range of tyrosine kinase inhibitors, including Lestaurtinib, Sunitinib, Sorafenib, and Dasatinib, can disrupt various signaling pathways crucial for cell proliferation and survival. The inhibition of these pathways by these chemicals can reduce the functional activity of TXR1 by limiting the signaling through pathways that TXR1 is associated with. Each of these chemical inhibitors operates through distinct but related mechanisms to modulate the activity of TXR1, reflecting the multifaceted regulation of this protein's function within cells.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3Ks). Since TXR1 is known to be associated with PI3K signaling, and PI3K activity is crucial for several cellular processes including survival and proliferation, the inhibition of PI3K by Wortmannin can lead to reduced activity of downstream proteins in the PI3K pathway, including TXR1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another well-known inhibitor of PI3Ks. By inhibiting PI3K, LY294002 can downregulate the PI3K/AKT pathway, which is a critical signaling pathway for cell survival and proliferation. The inhibition of this pathway can result in decreased function of proteins that are regulated by this pathway, such as TXR1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an inhibitor of mTOR (mammalian target of rapamycin). mTOR is a downstream target of PI3K/AKT signaling, and its inhibition can lead to decreased protein synthesis and cell proliferation. TXR1, being associated with these cellular processes, can be functionally inhibited as a consequence of mTOR inhibition. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $168.00 | ||
Spautin-1 is known to inhibit ubiquitin-specific peptidase 10 (USP10) and USP13, which are involved in the deubiquitination and stabilization of proteins. By inhibiting these USPs, Spautin-1 can cause destabilization and degradation of their substrate proteins, potentially including TXR1 if it is regulated by these USPs. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 acts as an inhibitor of MEK, which is upstream of the ERK pathway. The ERK pathway is implicated in various cellular processes, including cell cycle progression and proliferation. Inhibition of MEK by PD98059 can attenuate the ERK pathway's activity and subsequently reduce the functional capabilities of downstream proteins such as TXR1. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Similar to PD98059, U0126 is a selective inhibitor of MEK1 and MEK2. By impeding the MEK/ERK pathway, U0126 can suppress the function of proteins that are regulated by this signaling pathway, which may include the functional activity of TXR1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor that targets p38 MAP kinase. The p38 MAP kinase pathway is involved in the response to stress stimuli and is implicated in cell differentiation and apoptosis. Inhibition of p38 MAP kinase can lead to reduced activity of proteins associated with this pathway, including TXR1. | ||||||
Lestaurtinib | 111358-88-4 | sc-218657 sc-218657A sc-218657B | 1 mg 5 mg 10 mg | $275.00 $326.00 $612.00 | 3 | |
Lestaurtinib inhibits several tyrosine kinases, including JAK2. Tyrosine kinase signaling is crucial for various cellular functions, and inhibition of JAK2 can lead to diminished signaling through the JAK/STAT pathway, which might affect the function of associated proteins like TXR1. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor. It inhibits various receptors which could lead to the suppression of multiple signaling pathways, including those that might involve TXR1, thereby reducing its functional activity. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib is a kinase inhibitor that acts on multiple targets, including RAF kinase, VEGFR, and PDGFR. By inhibiting these kinases, Sorafenib can disrupt signaling pathways that are vital for cell proliferation and survival, potentially leading to inhibition of TXR1 function. | ||||||